Curanex Pharmaceuticals Inc Common Stock
CURX · NASDAQ
Market closed$0.205700$-0.012500 (-5.73%)After hours $0.205700 · 0.00%
Key statistics
Previous close$0.218200
Open$0.206000
Day high$0.220800
Day low$0.205600
52-week high$9.18
52-week low$0.205000
Market cap5.83M
Volume16.20K
Average volume90.79K
P/E ratio-0.73
Forward P/E—
EPS-0.28
Dividend yield0.00%
Market context
Why it moved
CURX shares declined amid broad market uncertainty driven by escalating geopolitical tensions following U.S. airstrikes on Iran, which dampened investor risk appetite and weighed on small-cap stocks.
What is happening
Recent company-specific developments and publisher coverage.
Investing.com · May 7, 2026Curanex Pharmaceuticals receives extension from Nasdaq to regain bid price complianceBusiness Wire · April 17, 2026Rosen Law Firm Encourages Curanex Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation – CURXStock Titan · April 8, 2026Five critically ill patient accounts inform Curanex's cachexia focusPluang · March 30, 2026Curanex advances Phyto-N toward IND submission for ulcerative colitis by late 2026GlobeNewswire · February 25, 2026Curanex Provides Operational Update on Key Regulatory Milestones Benzinga · December 9, 202512 Health Care Stocks Moving In Tuesday's After-Market Session Benzinga · December 3, 202512 Health Care Stocks Moving In Wednesday's Pre-Market Session Benzinga · November 28, 202512 Health Care Stocks Moving In Friday's Pre-Market Session Benzinga · November 26, 202512 Health Care Stocks Moving In Wednesday's Pre-Market Session Benzinga · August 26, 2025Curanex Pharmaceuticals Announces Pricing Of $15M Initial Public Offering Of 3.75M Shares At A Price Of $4/Share